The increased enzymatic activity of LDHB, restoration of the TCA cycle, and suppression of oncogenes via HIF-1α degradation contribute to the loss of malignancy in cancer cells while posing challenges for adaptation to hypoxia. This evidence concerns the gene LDHB and cancer.